Literature DB >> 1992098

A dot-ELISA mimicry western blot test for the detection of swine trichinellosis.

X Z Su1, A K Prestwood.   

Abstract

A dot enzyme-linked immunosorbent assay (dot-ELISA) using antigens purified by monoclonal antibody affinity chromatography was developed for detecting Trichinella spiralis infection in swine. The test was as sensitive as an ELISA using excretory-secretory products as antigen and western blot analysis, and nearly as specific as the western blot. The dot-ELISA detected all of 20 low infections (0.08-4.74 larvae per gram of diaphragm), most of them by 5-6 wk postinfection. Sera from 1,960 farm-reared swine were tested by conventional ELISA, dot-ELISA, and western blot. Of the 1,960 sera, 262 (13.4%) were considered positive on conventional ELISA, 16 (0.82%) by dot-ELISA, and 15 (0.77%) by western blot. The improved specificity was achieved by employing species-specific denatured antigens. More importantly, the dot-ELISA was much simpler to perform than western blot analysis. The principles employed in this test can be adapted to other infectious diseases, such as AIDS.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1992098

Source DB:  PubMed          Journal:  J Parasitol        ISSN: 0022-3395            Impact factor:   1.276


  3 in total

1.  Serological evaluation of thin-layer immunoassay-enzyme-linked immunosorbent assay for antibody detection in human trichinellosis.

Authors:  A Gómez-Priego; L Crecencio-Rosales; J L de-La-Rosa
Journal:  Clin Diagn Lab Immunol       Date:  2000-09

2.  Application and assessment of a dipstick assay in the diagnosis of hydatidosis and trichinosis.

Authors:  Maged M Al-Sherbiny; Abd-Al Magid M K Farrag; Mohamed H Fayad; Mohamed K Makled; Gihan M Tawfeek; Nehad M S Ali
Journal:  Parasitol Res       Date:  2004-04-22       Impact factor: 2.289

3.  Application of Western Blotting for the Post-Treatment Monitoring of Human Cystic Echinococcosis.

Authors:  Rajesh Kumar Tenguria; Mohd Irfan Naik; Bashir Fomda
Journal:  Iran J Public Health       Date:  2013-08       Impact factor: 1.429

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.